Global Antivirals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Antivirals market size was valued at USD 45910 million in 2023 and is forecast to a readjusted size of USD 61670 million by 2030 with a CAGR of 4.3% during review period.
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Antivirals industry chain, the market status of HIV (Generic, Branded), Hepatitis (Generic, Branded), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antivirals.
Regionally, the report analyzes the Antivirals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antivirals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antivirals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antivirals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Generic, Branded).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antivirals market.
Regional Analysis: The report involves examining the Antivirals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antivirals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antivirals:
Company Analysis: Report covers individual Antivirals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antivirals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (HIV, Hepatitis).
Technology Analysis: Report covers specific technologies relevant to Antivirals. It assesses the current state, advancements, and potential future developments in Antivirals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antivirals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antivirals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Antivirals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antivirals, with price, sales, revenue and global market share of Antivirals from 2019 to 2024.
Chapter 3, the Antivirals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antivirals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Antivirals market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antivirals.
Chapter 14 and 15, to describe Antivirals sales channel, distributors, customers, research findings and conclusion.
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Antivirals industry chain, the market status of HIV (Generic, Branded), Hepatitis (Generic, Branded), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antivirals.
Regionally, the report analyzes the Antivirals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antivirals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antivirals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antivirals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Generic, Branded).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antivirals market.
Regional Analysis: The report involves examining the Antivirals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antivirals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antivirals:
Company Analysis: Report covers individual Antivirals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antivirals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (HIV, Hepatitis).
Technology Analysis: Report covers specific technologies relevant to Antivirals. It assesses the current state, advancements, and potential future developments in Antivirals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antivirals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antivirals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Generic
- Branded
- HIV
- Hepatitis
- HSV
- Influenza
- Merck
- Johnson & Johnson
- Teva Pharmaceutical Industries
- GSK
- Mylan
- Gilead Sciences
- F. Hoffmann-La Roche
- Bristol-Myers-Squibb
- AbbVie
- Aurobindo Pharma
- Cipla
- Dr Reddy’s
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Antivirals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antivirals, with price, sales, revenue and global market share of Antivirals from 2019 to 2024.
Chapter 3, the Antivirals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antivirals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Antivirals market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antivirals.
Chapter 14 and 15, to describe Antivirals sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Antivirals
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antivirals Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Generic
1.3.3 Branded
1.4 Market Analysis by Application
1.4.1 Overview: Global Antivirals Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 HIV
1.4.3 Hepatitis
1.4.4 HSV
1.4.5 Influenza
1.5 Global Antivirals Market Size & Forecast
1.5.1 Global Antivirals Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Antivirals Sales Quantity (2019-2030)
1.5.3 Global Antivirals Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Antivirals Product and Services
2.1.4 Merck Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Antivirals Product and Services
2.2.4 Johnson & Johnson Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Teva Pharmaceutical Industries
2.3.1 Teva Pharmaceutical Industries Details
2.3.2 Teva Pharmaceutical Industries Major Business
2.3.3 Teva Pharmaceutical Industries Antivirals Product and Services
2.3.4 Teva Pharmaceutical Industries Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Antivirals Product and Services
2.4.4 GSK Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 GSK Recent Developments/Updates
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Antivirals Product and Services
2.5.4 Mylan Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Mylan Recent Developments/Updates
2.6 Gilead Sciences
2.6.1 Gilead Sciences Details
2.6.2 Gilead Sciences Major Business
2.6.3 Gilead Sciences Antivirals Product and Services
2.6.4 Gilead Sciences Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Gilead Sciences Recent Developments/Updates
2.7 F. Hoffmann-La Roche
2.7.1 F. Hoffmann-La Roche Details
2.7.2 F. Hoffmann-La Roche Major Business
2.7.3 F. Hoffmann-La Roche Antivirals Product and Services
2.7.4 F. Hoffmann-La Roche Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 F. Hoffmann-La Roche Recent Developments/Updates
2.8 Bristol-Myers-Squibb
2.8.1 Bristol-Myers-Squibb Details
2.8.2 Bristol-Myers-Squibb Major Business
2.8.3 Bristol-Myers-Squibb Antivirals Product and Services
2.8.4 Bristol-Myers-Squibb Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bristol-Myers-Squibb Recent Developments/Updates
2.9 AbbVie
2.9.1 AbbVie Details
2.9.2 AbbVie Major Business
2.9.3 AbbVie Antivirals Product and Services
2.9.4 AbbVie Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 AbbVie Recent Developments/Updates
2.10 Aurobindo Pharma
2.10.1 Aurobindo Pharma Details
2.10.2 Aurobindo Pharma Major Business
2.10.3 Aurobindo Pharma Antivirals Product and Services
2.10.4 Aurobindo Pharma Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Aurobindo Pharma Recent Developments/Updates
2.11 Cipla
2.11.1 Cipla Details
2.11.2 Cipla Major Business
2.11.3 Cipla Antivirals Product and Services
2.11.4 Cipla Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Cipla Recent Developments/Updates
2.12 Dr Reddy’s
2.12.1 Dr Reddy’s Details
2.12.2 Dr Reddy’s Major Business
2.12.3 Dr Reddy’s Antivirals Product and Services
2.12.4 Dr Reddy’s Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Dr Reddy’s Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTIVIRALS BY MANUFACTURER
3.1 Global Antivirals Sales Quantity by Manufacturer (2019-2024)
3.2 Global Antivirals Revenue by Manufacturer (2019-2024)
3.3 Global Antivirals Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Antivirals by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Antivirals Manufacturer Market Share in 2023
3.4.2 Top 6 Antivirals Manufacturer Market Share in 2023
3.5 Antivirals Market: Overall Company Footprint Analysis
3.5.1 Antivirals Market: Region Footprint
3.5.2 Antivirals Market: Company Product Type Footprint
3.5.3 Antivirals Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Antivirals Market Size by Region
4.1.1 Global Antivirals Sales Quantity by Region (2019-2030)
4.1.2 Global Antivirals Consumption Value by Region (2019-2030)
4.1.3 Global Antivirals Average Price by Region (2019-2030)
4.2 North America Antivirals Consumption Value (2019-2030)
4.3 Europe Antivirals Consumption Value (2019-2030)
4.4 Asia-Pacific Antivirals Consumption Value (2019-2030)
4.5 South America Antivirals Consumption Value (2019-2030)
4.6 Middle East and Africa Antivirals Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Antivirals Sales Quantity by Type (2019-2030)
5.2 Global Antivirals Consumption Value by Type (2019-2030)
5.3 Global Antivirals Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Antivirals Sales Quantity by Application (2019-2030)
6.2 Global Antivirals Consumption Value by Application (2019-2030)
6.3 Global Antivirals Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Antivirals Sales Quantity by Type (2019-2030)
7.2 North America Antivirals Sales Quantity by Application (2019-2030)
7.3 North America Antivirals Market Size by Country
7.3.1 North America Antivirals Sales Quantity by Country (2019-2030)
7.3.2 North America Antivirals Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Antivirals Sales Quantity by Type (2019-2030)
8.2 Europe Antivirals Sales Quantity by Application (2019-2030)
8.3 Europe Antivirals Market Size by Country
8.3.1 Europe Antivirals Sales Quantity by Country (2019-2030)
8.3.2 Europe Antivirals Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Antivirals Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Antivirals Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Antivirals Market Size by Region
9.3.1 Asia-Pacific Antivirals Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Antivirals Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Antivirals Sales Quantity by Type (2019-2030)
10.2 South America Antivirals Sales Quantity by Application (2019-2030)
10.3 South America Antivirals Market Size by Country
10.3.1 South America Antivirals Sales Quantity by Country (2019-2030)
10.3.2 South America Antivirals Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Antivirals Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Antivirals Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Antivirals Market Size by Country
11.3.1 Middle East & Africa Antivirals Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Antivirals Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Antivirals Market Drivers
12.2 Antivirals Market Restraints
12.3 Antivirals Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Antivirals and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antivirals
13.3 Antivirals Production Process
13.4 Antivirals Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antivirals Typical Distributors
14.3 Antivirals Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Antivirals
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antivirals Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Generic
1.3.3 Branded
1.4 Market Analysis by Application
1.4.1 Overview: Global Antivirals Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 HIV
1.4.3 Hepatitis
1.4.4 HSV
1.4.5 Influenza
1.5 Global Antivirals Market Size & Forecast
1.5.1 Global Antivirals Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Antivirals Sales Quantity (2019-2030)
1.5.3 Global Antivirals Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Antivirals Product and Services
2.1.4 Merck Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Antivirals Product and Services
2.2.4 Johnson & Johnson Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Teva Pharmaceutical Industries
2.3.1 Teva Pharmaceutical Industries Details
2.3.2 Teva Pharmaceutical Industries Major Business
2.3.3 Teva Pharmaceutical Industries Antivirals Product and Services
2.3.4 Teva Pharmaceutical Industries Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Antivirals Product and Services
2.4.4 GSK Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 GSK Recent Developments/Updates
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Antivirals Product and Services
2.5.4 Mylan Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Mylan Recent Developments/Updates
2.6 Gilead Sciences
2.6.1 Gilead Sciences Details
2.6.2 Gilead Sciences Major Business
2.6.3 Gilead Sciences Antivirals Product and Services
2.6.4 Gilead Sciences Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Gilead Sciences Recent Developments/Updates
2.7 F. Hoffmann-La Roche
2.7.1 F. Hoffmann-La Roche Details
2.7.2 F. Hoffmann-La Roche Major Business
2.7.3 F. Hoffmann-La Roche Antivirals Product and Services
2.7.4 F. Hoffmann-La Roche Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 F. Hoffmann-La Roche Recent Developments/Updates
2.8 Bristol-Myers-Squibb
2.8.1 Bristol-Myers-Squibb Details
2.8.2 Bristol-Myers-Squibb Major Business
2.8.3 Bristol-Myers-Squibb Antivirals Product and Services
2.8.4 Bristol-Myers-Squibb Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bristol-Myers-Squibb Recent Developments/Updates
2.9 AbbVie
2.9.1 AbbVie Details
2.9.2 AbbVie Major Business
2.9.3 AbbVie Antivirals Product and Services
2.9.4 AbbVie Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 AbbVie Recent Developments/Updates
2.10 Aurobindo Pharma
2.10.1 Aurobindo Pharma Details
2.10.2 Aurobindo Pharma Major Business
2.10.3 Aurobindo Pharma Antivirals Product and Services
2.10.4 Aurobindo Pharma Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Aurobindo Pharma Recent Developments/Updates
2.11 Cipla
2.11.1 Cipla Details
2.11.2 Cipla Major Business
2.11.3 Cipla Antivirals Product and Services
2.11.4 Cipla Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Cipla Recent Developments/Updates
2.12 Dr Reddy’s
2.12.1 Dr Reddy’s Details
2.12.2 Dr Reddy’s Major Business
2.12.3 Dr Reddy’s Antivirals Product and Services
2.12.4 Dr Reddy’s Antivirals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Dr Reddy’s Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTIVIRALS BY MANUFACTURER
3.1 Global Antivirals Sales Quantity by Manufacturer (2019-2024)
3.2 Global Antivirals Revenue by Manufacturer (2019-2024)
3.3 Global Antivirals Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Antivirals by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Antivirals Manufacturer Market Share in 2023
3.4.2 Top 6 Antivirals Manufacturer Market Share in 2023
3.5 Antivirals Market: Overall Company Footprint Analysis
3.5.1 Antivirals Market: Region Footprint
3.5.2 Antivirals Market: Company Product Type Footprint
3.5.3 Antivirals Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Antivirals Market Size by Region
4.1.1 Global Antivirals Sales Quantity by Region (2019-2030)
4.1.2 Global Antivirals Consumption Value by Region (2019-2030)
4.1.3 Global Antivirals Average Price by Region (2019-2030)
4.2 North America Antivirals Consumption Value (2019-2030)
4.3 Europe Antivirals Consumption Value (2019-2030)
4.4 Asia-Pacific Antivirals Consumption Value (2019-2030)
4.5 South America Antivirals Consumption Value (2019-2030)
4.6 Middle East and Africa Antivirals Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Antivirals Sales Quantity by Type (2019-2030)
5.2 Global Antivirals Consumption Value by Type (2019-2030)
5.3 Global Antivirals Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Antivirals Sales Quantity by Application (2019-2030)
6.2 Global Antivirals Consumption Value by Application (2019-2030)
6.3 Global Antivirals Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Antivirals Sales Quantity by Type (2019-2030)
7.2 North America Antivirals Sales Quantity by Application (2019-2030)
7.3 North America Antivirals Market Size by Country
7.3.1 North America Antivirals Sales Quantity by Country (2019-2030)
7.3.2 North America Antivirals Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Antivirals Sales Quantity by Type (2019-2030)
8.2 Europe Antivirals Sales Quantity by Application (2019-2030)
8.3 Europe Antivirals Market Size by Country
8.3.1 Europe Antivirals Sales Quantity by Country (2019-2030)
8.3.2 Europe Antivirals Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Antivirals Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Antivirals Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Antivirals Market Size by Region
9.3.1 Asia-Pacific Antivirals Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Antivirals Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Antivirals Sales Quantity by Type (2019-2030)
10.2 South America Antivirals Sales Quantity by Application (2019-2030)
10.3 South America Antivirals Market Size by Country
10.3.1 South America Antivirals Sales Quantity by Country (2019-2030)
10.3.2 South America Antivirals Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Antivirals Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Antivirals Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Antivirals Market Size by Country
11.3.1 Middle East & Africa Antivirals Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Antivirals Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Antivirals Market Drivers
12.2 Antivirals Market Restraints
12.3 Antivirals Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Antivirals and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antivirals
13.3 Antivirals Production Process
13.4 Antivirals Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antivirals Typical Distributors
14.3 Antivirals Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 2. Global Antivirals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Antivirals Product and Services
Table 6. Merck Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Antivirals Product and Services
Table 11. Johnson & Johnson Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Industries Major Business
Table 15. Teva Pharmaceutical Industries Antivirals Product and Services
Table 16. Teva Pharmaceutical Industries Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Teva Pharmaceutical Industries Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK Antivirals Product and Services
Table 21. GSK Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. GSK Recent Developments/Updates
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Antivirals Product and Services
Table 26. Mylan Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Mylan Recent Developments/Updates
Table 28. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 29. Gilead Sciences Major Business
Table 30. Gilead Sciences Antivirals Product and Services
Table 31. Gilead Sciences Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Gilead Sciences Recent Developments/Updates
Table 33. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 34. F. Hoffmann-La Roche Major Business
Table 35. F. Hoffmann-La Roche Antivirals Product and Services
Table 36. F. Hoffmann-La Roche Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. F. Hoffmann-La Roche Recent Developments/Updates
Table 38. Bristol-Myers-Squibb Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers-Squibb Major Business
Table 40. Bristol-Myers-Squibb Antivirals Product and Services
Table 41. Bristol-Myers-Squibb Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bristol-Myers-Squibb Recent Developments/Updates
Table 43. AbbVie Basic Information, Manufacturing Base and Competitors
Table 44. AbbVie Major Business
Table 45. AbbVie Antivirals Product and Services
Table 46. AbbVie Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. AbbVie Recent Developments/Updates
Table 48. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Aurobindo Pharma Major Business
Table 50. Aurobindo Pharma Antivirals Product and Services
Table 51. Aurobindo Pharma Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Aurobindo Pharma Recent Developments/Updates
Table 53. Cipla Basic Information, Manufacturing Base and Competitors
Table 54. Cipla Major Business
Table 55. Cipla Antivirals Product and Services
Table 56. Cipla Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Cipla Recent Developments/Updates
Table 58. Dr Reddy’s Basic Information, Manufacturing Base and Competitors
Table 59. Dr Reddy’s Major Business
Table 60. Dr Reddy’s Antivirals Product and Services
Table 61. Dr Reddy’s Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Dr Reddy’s Recent Developments/Updates
Table 63. Global Antivirals Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 64. Global Antivirals Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Antivirals Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 66. Market Position of Manufacturers in Antivirals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Antivirals Production Site of Key Manufacturer
Table 68. Antivirals Market: Company Product Type Footprint
Table 69. Antivirals Market: Company Product Application Footprint
Table 70. Antivirals New Market Entrants and Barriers to Market Entry
Table 71. Antivirals Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Antivirals Sales Quantity by Region (2019-2024) & (K MT)
Table 73. Global Antivirals Sales Quantity by Region (2025-2030) & (K MT)
Table 74. Global Antivirals Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Antivirals Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Antivirals Average Price by Region (2019-2024) & (USD/MT)
Table 77. Global Antivirals Average Price by Region (2025-2030) & (USD/MT)
Table 78. Global Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 79. Global Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 80. Global Antivirals Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Antivirals Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Antivirals Average Price by Type (2019-2024) & (USD/MT)
Table 83. Global Antivirals Average Price by Type (2025-2030) & (USD/MT)
Table 84. Global Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 85. Global Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 86. Global Antivirals Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Antivirals Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Antivirals Average Price by Application (2019-2024) & (USD/MT)
Table 89. Global Antivirals Average Price by Application (2025-2030) & (USD/MT)
Table 90. North America Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 91. North America Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 92. North America Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 93. North America Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 94. North America Antivirals Sales Quantity by Country (2019-2024) & (K MT)
Table 95. North America Antivirals Sales Quantity by Country (2025-2030) & (K MT)
Table 96. North America Antivirals Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Antivirals Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 99. Europe Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 100. Europe Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 101. Europe Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 102. Europe Antivirals Sales Quantity by Country (2019-2024) & (K MT)
Table 103. Europe Antivirals Sales Quantity by Country (2025-2030) & (K MT)
Table 104. Europe Antivirals Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Antivirals Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 107. Asia-Pacific Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 108. Asia-Pacific Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 109. Asia-Pacific Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 110. Asia-Pacific Antivirals Sales Quantity by Region (2019-2024) & (K MT)
Table 111. Asia-Pacific Antivirals Sales Quantity by Region (2025-2030) & (K MT)
Table 112. Asia-Pacific Antivirals Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Antivirals Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 115. South America Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 116. South America Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 117. South America Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 118. South America Antivirals Sales Quantity by Country (2019-2024) & (K MT)
Table 119. South America Antivirals Sales Quantity by Country (2025-2030) & (K MT)
Table 120. South America Antivirals Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Antivirals Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 123. Middle East & Africa Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 124. Middle East & Africa Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 125. Middle East & Africa Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 126. Middle East & Africa Antivirals Sales Quantity by Region (2019-2024) & (K MT)
Table 127. Middle East & Africa Antivirals Sales Quantity by Region (2025-2030) & (K MT)
Table 128. Middle East & Africa Antivirals Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Antivirals Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Antivirals Raw Material
Table 131. Key Manufacturers of Antivirals Raw Materials
Table 132. Antivirals Typical Distributors
Table 133. Antivirals Typical Customers
Table 2. Global Antivirals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Antivirals Product and Services
Table 6. Merck Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Antivirals Product and Services
Table 11. Johnson & Johnson Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Industries Major Business
Table 15. Teva Pharmaceutical Industries Antivirals Product and Services
Table 16. Teva Pharmaceutical Industries Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Teva Pharmaceutical Industries Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK Antivirals Product and Services
Table 21. GSK Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. GSK Recent Developments/Updates
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Antivirals Product and Services
Table 26. Mylan Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Mylan Recent Developments/Updates
Table 28. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 29. Gilead Sciences Major Business
Table 30. Gilead Sciences Antivirals Product and Services
Table 31. Gilead Sciences Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Gilead Sciences Recent Developments/Updates
Table 33. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 34. F. Hoffmann-La Roche Major Business
Table 35. F. Hoffmann-La Roche Antivirals Product and Services
Table 36. F. Hoffmann-La Roche Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. F. Hoffmann-La Roche Recent Developments/Updates
Table 38. Bristol-Myers-Squibb Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers-Squibb Major Business
Table 40. Bristol-Myers-Squibb Antivirals Product and Services
Table 41. Bristol-Myers-Squibb Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bristol-Myers-Squibb Recent Developments/Updates
Table 43. AbbVie Basic Information, Manufacturing Base and Competitors
Table 44. AbbVie Major Business
Table 45. AbbVie Antivirals Product and Services
Table 46. AbbVie Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. AbbVie Recent Developments/Updates
Table 48. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Aurobindo Pharma Major Business
Table 50. Aurobindo Pharma Antivirals Product and Services
Table 51. Aurobindo Pharma Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Aurobindo Pharma Recent Developments/Updates
Table 53. Cipla Basic Information, Manufacturing Base and Competitors
Table 54. Cipla Major Business
Table 55. Cipla Antivirals Product and Services
Table 56. Cipla Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Cipla Recent Developments/Updates
Table 58. Dr Reddy’s Basic Information, Manufacturing Base and Competitors
Table 59. Dr Reddy’s Major Business
Table 60. Dr Reddy’s Antivirals Product and Services
Table 61. Dr Reddy’s Antivirals Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Dr Reddy’s Recent Developments/Updates
Table 63. Global Antivirals Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 64. Global Antivirals Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Antivirals Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 66. Market Position of Manufacturers in Antivirals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Antivirals Production Site of Key Manufacturer
Table 68. Antivirals Market: Company Product Type Footprint
Table 69. Antivirals Market: Company Product Application Footprint
Table 70. Antivirals New Market Entrants and Barriers to Market Entry
Table 71. Antivirals Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Antivirals Sales Quantity by Region (2019-2024) & (K MT)
Table 73. Global Antivirals Sales Quantity by Region (2025-2030) & (K MT)
Table 74. Global Antivirals Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Antivirals Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Antivirals Average Price by Region (2019-2024) & (USD/MT)
Table 77. Global Antivirals Average Price by Region (2025-2030) & (USD/MT)
Table 78. Global Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 79. Global Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 80. Global Antivirals Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Antivirals Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Antivirals Average Price by Type (2019-2024) & (USD/MT)
Table 83. Global Antivirals Average Price by Type (2025-2030) & (USD/MT)
Table 84. Global Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 85. Global Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 86. Global Antivirals Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Antivirals Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Antivirals Average Price by Application (2019-2024) & (USD/MT)
Table 89. Global Antivirals Average Price by Application (2025-2030) & (USD/MT)
Table 90. North America Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 91. North America Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 92. North America Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 93. North America Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 94. North America Antivirals Sales Quantity by Country (2019-2024) & (K MT)
Table 95. North America Antivirals Sales Quantity by Country (2025-2030) & (K MT)
Table 96. North America Antivirals Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Antivirals Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 99. Europe Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 100. Europe Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 101. Europe Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 102. Europe Antivirals Sales Quantity by Country (2019-2024) & (K MT)
Table 103. Europe Antivirals Sales Quantity by Country (2025-2030) & (K MT)
Table 104. Europe Antivirals Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Antivirals Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 107. Asia-Pacific Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 108. Asia-Pacific Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 109. Asia-Pacific Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 110. Asia-Pacific Antivirals Sales Quantity by Region (2019-2024) & (K MT)
Table 111. Asia-Pacific Antivirals Sales Quantity by Region (2025-2030) & (K MT)
Table 112. Asia-Pacific Antivirals Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Antivirals Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 115. South America Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 116. South America Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 117. South America Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 118. South America Antivirals Sales Quantity by Country (2019-2024) & (K MT)
Table 119. South America Antivirals Sales Quantity by Country (2025-2030) & (K MT)
Table 120. South America Antivirals Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Antivirals Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Antivirals Sales Quantity by Type (2019-2024) & (K MT)
Table 123. Middle East & Africa Antivirals Sales Quantity by Type (2025-2030) & (K MT)
Table 124. Middle East & Africa Antivirals Sales Quantity by Application (2019-2024) & (K MT)
Table 125. Middle East & Africa Antivirals Sales Quantity by Application (2025-2030) & (K MT)
Table 126. Middle East & Africa Antivirals Sales Quantity by Region (2019-2024) & (K MT)
Table 127. Middle East & Africa Antivirals Sales Quantity by Region (2025-2030) & (K MT)
Table 128. Middle East & Africa Antivirals Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Antivirals Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Antivirals Raw Material
Table 131. Key Manufacturers of Antivirals Raw Materials
Table 132. Antivirals Typical Distributors
Table 133. Antivirals Typical Customers
LIST OF FIGURES
Figure 2. Global Antivirals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Antivirals Consumption Value Market Share by Type in 2023
Figure 4. Generic Examples
Figure 5. Branded Examples
Figure 6. Global Antivirals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Antivirals Consumption Value Market Share by Application in 2023
Figure 8. HIV Examples
Figure 9. Hepatitis Examples
Figure 10. HSV Examples
Figure 11. Influenza Examples
Figure 12. Global Antivirals Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Antivirals Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Antivirals Sales Quantity (2019-2030) & (K MT)
Figure 15. Global Antivirals Average Price (2019-2030) & (USD/MT)
Figure 16. Global Antivirals Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Antivirals Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Antivirals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Antivirals Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Antivirals Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Antivirals Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Antivirals Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Antivirals Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Antivirals Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Antivirals Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Antivirals Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Antivirals Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Antivirals Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Antivirals Average Price by Type (2019-2030) & (USD/MT)
Figure 31. Global Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Antivirals Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Antivirals Average Price by Application (2019-2030) & (USD/MT)
Figure 34. North America Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Antivirals Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Antivirals Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Antivirals Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Antivirals Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Antivirals Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Antivirals Consumption Value Market Share by Region (2019-2030)
Figure 54. China Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Antivirals Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Antivirals Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Antivirals Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Antivirals Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Antivirals Market Drivers
Figure 75. Antivirals Market Restraints
Figure 76. Antivirals Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Antivirals in 2023
Figure 79. Manufacturing Process Analysis of Antivirals
Figure 80. Antivirals Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 2. Global Antivirals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Antivirals Consumption Value Market Share by Type in 2023
Figure 4. Generic Examples
Figure 5. Branded Examples
Figure 6. Global Antivirals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Antivirals Consumption Value Market Share by Application in 2023
Figure 8. HIV Examples
Figure 9. Hepatitis Examples
Figure 10. HSV Examples
Figure 11. Influenza Examples
Figure 12. Global Antivirals Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Antivirals Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Antivirals Sales Quantity (2019-2030) & (K MT)
Figure 15. Global Antivirals Average Price (2019-2030) & (USD/MT)
Figure 16. Global Antivirals Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Antivirals Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Antivirals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Antivirals Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Antivirals Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Antivirals Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Antivirals Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Antivirals Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Antivirals Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Antivirals Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Antivirals Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Antivirals Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Antivirals Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Antivirals Average Price by Type (2019-2030) & (USD/MT)
Figure 31. Global Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Antivirals Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Antivirals Average Price by Application (2019-2030) & (USD/MT)
Figure 34. North America Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Antivirals Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Antivirals Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Antivirals Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Antivirals Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Antivirals Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Antivirals Consumption Value Market Share by Region (2019-2030)
Figure 54. China Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Antivirals Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Antivirals Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Antivirals Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Antivirals Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Antivirals Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Antivirals Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Antivirals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Antivirals Market Drivers
Figure 75. Antivirals Market Restraints
Figure 76. Antivirals Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Antivirals in 2023
Figure 79. Manufacturing Process Analysis of Antivirals
Figure 80. Antivirals Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
More Publications
Global Hepatitis C Virus (HCV) Antiviral Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
US$ 3,480.00
November 2018
123 pages
